The NLRP3 Inflammasome as a Novel Therapeutic Target for Cardiac Fibrosis

Cardiac fibrosis often has adverse cardiovascular effects, including heart failure, sudden death, and malignant arrhythmias. However, there is no targeted therapy for cardiac fibrosis. Inflammation is known to play a crucial role in the disorder, and the NLR pyrin domain-containing-3 (NLRP3) inflamm...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Jiwen, Ren, Meng, Adhikari, Binay Kumar, Wang, Haodong, He, Yuquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273832/
https://www.ncbi.nlm.nih.gov/pubmed/35836721
http://dx.doi.org/10.2147/JIR.S370483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273832/
https://www.ncbi.nlm.nih.gov/pubmed/35836721
http://dx.doi.org/10.2147/JIR.S370483

Ejemplares similares